These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Forging forward with 10 burning questions on FGF23 in kidney disease. Wolf M J Am Soc Nephrol; 2010 Sep; 21(9):1427-35. PubMed ID: 20507943 [TBL] [Abstract][Full Text] [Related]
33. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia. Han SY; Hwang EA; Park SB; Kim HC; Kim HT Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462 [TBL] [Abstract][Full Text] [Related]
34. [Fibroblast growth factor 23/Klotho system in the context of cardiovascular damage]. Donate-Correa J; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF Med Clin (Barc); 2013 May; 140(9):420-3. PubMed ID: 23337450 [No Abstract] [Full Text] [Related]
35. Crystal-induced kidney disease in 2 kidney transplant recipients. Parasuraman R; Venkat KK Am J Kidney Dis; 2010 Jan; 55(1):192-7. PubMed ID: 19880229 [No Abstract] [Full Text] [Related]
36. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients. Barros X; Torregrosa JV; Martínez de Osaba MJ; Casals G; Paschoalin R; Durán CE; Campistol JM Transplantation; 2012 Oct; 94(8):830-6. PubMed ID: 23018879 [TBL] [Abstract][Full Text] [Related]
37. Phosphate and FGF-23 homeostasis after kidney transplantation. Baia LC; Heilberg IP; Navis G; de Borst MH; Nat Rev Nephrol; 2015 Nov; 11(11):656-66. PubMed ID: 26416497 [TBL] [Abstract][Full Text] [Related]
38. [Kidney and bone update : the 5-year history and future of CKD-MBD. Mineral and bone disorder in kidney transplant recipients]. Fujii N; Okuno A; Yonemoto S; Nishimura K; Kishikawa H; Ichikawa Y Clin Calcium; 2012 Jul; 22(7):1050-8. PubMed ID: 22750938 [TBL] [Abstract][Full Text] [Related]
39. [Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho]. Milovanova LIu; Kozlovskaia LV; Milovanov IuS; Bobkova IN; Dobrosmyslov IA Ter Arkh; 2010; 82(6):66-72. PubMed ID: 20731116 [TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]